PharmaTimes - May 2020

COVID-19 will rightfully continue to dominate the news and our thoughts over the course of the pandemic and beyond, but it is also important to highlight some of the great positives of pharma and healthcare that can risk going unnoticed, particularly during times of crisis.

As such, as well as keeping you up-to-date on coronavirus and other, unrelated industry developments in our daily news stream and PharmaTimes Magazine, we have exciting news to announce.

For one, we have significantly upgraded the digital edition of PharmaTimes Magazine (http://magazine.pharmatimes.com/) with new design features to further improve readability on mobile, tablet and desktop devices.

This issue sees the first ever annual Women in Healthcare feature, which kicks off on page 18 and is simply designed to highlight some of the brightest stars in pharma and healthcare and their successes.

Alongside partner OVID Health, PharmaTimes is also thrilled to launch the new Patient Partnership Index, which will celebrate the pharma companies that really stand out with regard to their communication and engagement with patient groups, thus providing a valuable platform for learning and spreading best practice in meaningful patient-centricity.

See Jenny Ousbey’s related article on the need for thriving partnerships between pharma and patient groups on page 14.

I hope you enjoy the issue!

May 2020 - magazine highlights

Shuffling priorities

Stuart Henderson considers the need to transform clinical...

Women in Healthcare: Bianca Coulter

Bianca Coulter, Coulter Partners, Chief Executive

Women in Healthcare: Ebony Samuels

Ebony Samuels, Parexel International, Vice President

Women in Healthcare: Sarah Price

Sarah Price, Havas Lynx Group, Director of Media

Women in Healthcare: Claire Knapp

Claire Knapp, Havas Lynx Group, Managing Director

Women in Healthcare: Deborah Kobewka

Deborah Kobewka, Evaluate, Chief Executive

Women in Healthcare: Dr Dennise Broderick

Dr Dennise Broderick, Galen, President and Managing Direct...

Women in Healthcare: Laura Coyle

Laura Coyle, Lundbeck, District Manager

Women in Healthcare: Dr Juliet Roberts

Dr Juliet Roberts, Boehringer Ingelheim, UK & Ireland Medi...

Women in Healthcare: Victoria Blackbeard

Victoria Blackbeard, Eradigm Consulting, Consultant

Women in Healthcare: Caroline Kelly

Caroline Kelly, Pharma Integrity, Managing Director

Women in Healthcare: Sarah Scanlon

Sarah Scanlon, Janssen, Business Unit Director: Oncology,...

Women in Healthcare: Dima Samaha

Dima Samaha, Certara, Senior Director - Value Strategy & P...

Women in Healthcare: Emma Rooth

Emma Rooth, Torbay Pharmaceuticals, Managing Director

Women in Healthcare: Harriet Lewis

Harriet Lewis, Chiesi, Head of Public Affairs

Women in Healthcare: Kim Innes

Kim Innes, Teva UK, General Manager UK & Ireland

Women in Healthcare: Stephanie Hall

Stephanie Hall, Uptake Strategies, Managing Director and F...

Women in Healthcare: Elizabeth Rapley

Elizabeth Rapley, Edge Medical Communications, Managing Di...

Women in Healthcare: Johanna Jarvis

Johanna Jarvis, Pi Healthcare, Managing Director

Women in Healthcare: Shairose Ebrahim

Shairose Ebrahim, integrated medhealth communication (imc)...

Women in Healthcare: Dr Nuala Murphy

Dr Nuala Murphy, ICON plc, President Clinical Research Ser...

Women in Healthcare: Ellie Matthews

Ellie Matthews, Bionical Emas, Head of Project Management,...

Women in Healthcare: Claire Bennett

Claire Bennett, Bionical Emas, Vice President of Data Mana...

Patient Files: Haemophilia A

PharmaTimes talks to Carreen McCay about her 10 year-old s...

Turning the spotlight on mental health in cancer care

Roshani Perera looks at the provision of psychological sup...

Building trust

Would you trust a pharma brand with your life?

Clarity calls

After ploughing untold investment into building comprehens...

Personalising population health

How personalised medicine and population health can work t...

A ticking time bomb

Steve How and Oli Hudson, of Wilmington Healthcare, assess...

A shared perspective

We need partnerships between pharma and patient groups to...